Matisse Capital

Q2 2026 13F-HR Holdings

Location
Portland, OR
Holdings as of
6/30/2026
Date filed
8/12/2026
Form type
13F-HR
Num holdings
158
Total value ($000)
$249,756
Net value change ($000)
+15,311 (6.5%)
New positions
16
Sold out positions
21
Turnover %
13.9%
Sector allocation + QoQ delta (equities-only)
Prev filing: 5/8/2026 Next filing: — SEC filing

Snapshot: Change Analysis

Compared to Q1 2026
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
Ascendis Pharma AS 7,497 NEW
LRCX 3,769 92.2%
KF 2,493 67.5%
EVF 1,706 1245.3%
DHY 1,297 NEW
AAPL 1,273 13.9%
SWZ 1,202 49.8%
TWN 1,156 20.9%
EFR 1,060 NEW
GOOGL 906 24.3%
Top Reduces (Value $000, Stocks/ETFs)
ASND -5,965 -100.0%
BTX -3,914 -100.0%
MXF -1,984 -46.2%
BTT -1,851 -100.0%
V -1,100 -100.0%
CAF -1,044 -33.5%
TSCO -830 -100.0%
NTR -774 -100.0%
STE -751 -100.0%
BABA -694 -100.0%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type